Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 3/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4706621 | 0.87 | L3MBTL1 (0.48) | MGLLL3MBTL1ENPP2LMNASMN1; SMN2 | |
| SCHEMBL3858457 | 0.84 | MGLL (0.44) | MGLLENPP2SMN1; SMN2MEN1KMT2A | |
| SCHEMBL3862893 | 0.83 | PPARG (0.47) | MGLLL3MBTL1ENPP2 | |
| SCHEMBL3946212 | 0.83 | PPARG (0.47) | MGLLL3MBTL1ENPP2 | |
| SCHEMBL3862897 | 0.83 | PPARG (0.47) | MGLLL3MBTL1ENPP2 | |
| SCHEMBL3857652 | 0.81 | PPARG (0.45) | MGLL | |
| SCHEMBL13619498 | 0.79 | PPARG (0.43) | MGLLL3MBTL1 | |
| SCHEMBL13619486 | 0.79 | PPARG (0.43) | MGLLL3MBTL1 | |
| SCHEMBL4704709 | 0.78 | CTSK (0.45) | L3MBTL1LMNASMN1; SMN2KMT2A | |
| SCHEMBL31188097 | 0.76 | LMNA (0.50) | L3MBTL1LMNASMN1; SMN2MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1971582-A1 | MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS | Brystol-Myers Squibb Company (US) | 2008-09-24 | — | — | EP | disclosed |
| WO-2007076431-A1 | MACROCYCLIC FACTOR VIIA INHIBITORS USEFUL AS ANTICOAGULANTS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2007-07-05 | — | — | WO | disclosed |